12,607 Shares in Kenvue Inc. (NYSE:KVUE) Acquired by Commerzbank Aktiengesellschaft FI

Commerzbank Aktiengesellschaft FI bought a new stake in shares of Kenvue Inc. (NYSE:KVUE) in the third quarter, HoldingsChannel reports. The institutional investor bought 12,607 shares of the company’s stock, valued at approximately $292,000.

Several other hedge funds have also made changes to their positions in the company. Cornerstone Wealth Group LLC boosted its stake in shares of Kenvue by 176.2% during the first quarter. Cornerstone Wealth Group LLC now owns 350,371 shares of the company’s stock valued at $7,519,000 after purchasing an additional 223,537 shares in the last quarter. Janney Montgomery Scott LLC lifted its holdings in Kenvue by 56.2% during the first quarter. Janney Montgomery Scott LLC now owns 1,840,875 shares of the company’s stock worth $39,505,000 after buying an additional 662,666 shares during the period. BI Asset Management Fondsmaeglerselskab A S bought a new stake in Kenvue during the 1st quarter valued at $1,050,000. Norden Group LLC purchased a new position in shares of Kenvue in the 1st quarter valued at $1,792,000. Finally, Lorne Steinberg Wealth Management Inc. raised its position in shares of Kenvue by 59.0% in the 2nd quarter. Lorne Steinberg Wealth Management Inc. now owns 154,690 shares of the company’s stock worth $2,812,000 after acquiring an additional 57,375 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on KVUE shares. Jefferies Financial Group started coverage on Kenvue in a research report on Tuesday, September 24th. They set a “buy” rating and a $27.00 price objective on the stock. UBS Group lifted their price objective on shares of Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. Citigroup decreased their target price on shares of Kenvue from $21.00 to $20.00 and set a “neutral” rating for the company in a research report on Wednesday, July 10th. Royal Bank of Canada lowered shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price target on the stock. in a report on Tuesday, September 24th. Finally, Piper Sandler increased their price objective on Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Kenvue has a consensus rating of “Hold” and a consensus target price of $22.64.

Kenvue Price Performance

Shares of NYSE KVUE opened at $22.96 on Friday. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $23.55. The company has a quick ratio of 0.68, a current ratio of 0.99 and a debt-to-equity ratio of 0.69. The firm has a market cap of $43.95 billion, a P/E ratio of 29.43, a P/E/G ratio of 2.76 and a beta of 1.40. The business’s 50 day moving average price is $22.39 and its 200 day moving average price is $20.28.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.28 by $0.04. Kenvue had a net margin of 7.23% and a return on equity of 21.80%. The business had revenue of $4 billion for the quarter, compared to the consensus estimate of $3.93 billion. During the same period in the prior year, the firm earned $0.32 EPS. The business’s revenue for the quarter was down .3% on a year-over-year basis. On average, sell-side analysts expect that Kenvue Inc. will post 1.08 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th will be issued a $0.205 dividend. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.82 annualized dividend and a dividend yield of 3.57%. Kenvue’s dividend payout ratio (DPR) is presently 105.13%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.